Vimta Labs share price
You have to be logged in to add this to Watchlist.- ₹544.00(-2.05%)January 16, 2026 15:29:58 PM IST
- NSE
- BSE
- Vol : 106.55 K (NSE + BSE)Last 20 day avg : 134.10 K
Vimta Labs is trading -2.05% lower at Rs 544.00 as compared to its last closing price. Vimta Labs has been trading in the price range of 563.55 & 541.55. Vimta Labs has given -8.25% in this year & -10.08% in the last 5 days. Vimta Labs has TTM P/E ratio 42.18 as compared to the sector P/E of 38.36.The company posted a net profit of 19.92 Crores in its last quarter.Listed peers of Vimta Labs include Torrent Pharmaceuticals (0.35%), Dr Reddy's Laboratories (-0.91%), Sun Pharmaceutical Industries (-1.84%).The Mutual Fund holding in Vimta Labs was at 0.13% in 31 Dec 2024. The MF holding has decreased from the last quarter. The FII holding in Vimta Labs was at 4.33% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 18, 2026, 09:00 PM UTC
- BetaLow volatility-0.35Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.36Annual dividends as a percentage of the stock price.
- PEG RatioIndicates Fair Valuation1.83The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 4,018.75 | 0.35 | 1,36,007.30 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Bearish | 1,175.65 | -0.91 | 98,110.38 | 18.63 | 3.14 | 0.63 | 2.34 |
| Sun Pharmaceutical Industries | Bearish | 1,669.20 | -1.84 | 4,00,487.56 | 36.24 | 5.77 | 0.92 | 0.50 |
| Divi's Laboratories | Bearish | 6,233.95 | -1.93 | 1,65,491.79 | 78.61 | 11.52 | 0.46 | 0.01 |
| Cipla | Bearish | 1,398.45 | -2.52 | 1,12,922.46 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-03 | Quarterly Results |
| 2025-07-17 | Quarterly Results |
| 2025-06-14 | Others |
| 2025-04-28 | Audited Results, Dividend & Bonus issue |
| 2025-01-24 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE579C01029
- BSE Code524394
- NSE CodeVIMTALABS
Vimta Labs is trading at 544.00 as on Fri Jan 16 2026 09:59:58. This is -2.05% lower as compared to its previous closing price of 555.40.
The market capitalization of Vimta Labs is 2430.83 Cr as on Fri Jan 16 2026 09:59:58.
The 52 wk high for Vimta Labs is 902.85 whereas the 52 wk low is 372.50
Vimta Labs can be analyzed on the following key metrics -
- TTM P/E: 42.18
- Sector P/E: 38.36
- Dividend Yield: 0.36%
- D/E ratio: 0.02
Vimta Labs reported a net profit of 67.34 Cr in 2025.
The Mutual Fund Shareholding was 0.13% at the end of 31 Dec 2024.
EQUITY QUICK LINKS
Vimta Labs QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.